# FDA Inspection 812389 - Shoreline Medical LLC - December 19, 2012

Source: https://www.keypedia.com/records/fda_inspections/shoreline-medical-llc/4b0e5609-c5e4-4b6b-a79a-919211647c91
Source feed: FDA_Inspections

> FDA Inspection 812389 for Shoreline Medical LLC on December 19, 2012. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 812389
- Company Name: Shoreline Medical LLC
- Inspection Date: 2012-12-19
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 991879 - 2016-11-07](https://www.keypedia.com/records/fda_inspections/shoreline-medical-llc/36bd2130-284a-4029-b5d6-a7b711b0c1a8)
- [FDA Inspection 991879 - 2016-11-07](https://www.keypedia.com/records/fda_inspections/shoreline-medical-llc/eed018b5-65fc-4c00-82d8-eb47cd695223)

Company: https://www.keypedia.com/companies/shoreline-medical-llc/8d8d2c06-661d-48b3-8156-83495c7c38e9

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d